Vital KSK Holdings, Inc.

Tokyo Stock Exchange 3151.T

Vital KSK Holdings, Inc. Current Liabilities for the year ending March 31, 2024: USD 1.28 B

Vital KSK Holdings, Inc. Current Liabilities is USD 1.28 B for the year ending March 31, 2024, a -4.98% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Vital KSK Holdings, Inc. Current Liabilities for the year ending March 31, 2023 was USD 1.34 B, a -13.89% change year over year.
Vital KSK Holdings, Inc. Current Liabilities for the year ending March 31, 2022 was USD 1.56 B, a -3.08% change year over year.
Vital KSK Holdings, Inc. Current Liabilities for the year ending March 31, 2021 was USD 1.61 B, a -2.75% change year over year.
Vital KSK Holdings, Inc. Current Liabilities for the year ending March 31, 2020 was USD 1.66 B, a -7.64% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Tokyo Stock Exchange: 3151.T

Vital KSK Holdings, Inc.

CEO	Mr. Taisuke Murai
IPO Date	Jan. 1, 2001
Location	Japan
Headquarters	1-1-12, Tsurumaki
Employees	3,705
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Retail & Wholesale

Description

Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years